Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.07 USD | -4.60% | +55.18% | +30.20% |
Jun. 07 | Structure Therapeutics Closes $547.4 Million Offering | MT |
Jun. 07 | BMO Capital Adjusts Price Target on Structure Therapeutics to $100 From $83, Maintains Outperform Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 55.56M | Capitalization | 2.47B |
---|---|---|---|---|---|
Net income 2024 * | -132M | Net income 2025 * | -123M | EV / Sales 2024 * | - |
Net cash position 2024 * | 336M | Net cash position 2025 * | 156M | EV / Sales 2025 * | 41.7 x |
P/E ratio 2024 * |
-57.7
x | P/E ratio 2025 * |
-65.8
x | Employees | 111 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.06% |
Latest transcript on Structure Therapeutics Inc.
1 day | -4.60% | ||
1 week | +55.18% | ||
Current month | +55.18% | ||
1 month | +35.31% | ||
3 months | +43.98% | ||
6 months | -14.22% | ||
Current year | +30.20% |
Managers | Title | Age | Since |
---|---|---|---|
Raymond Stevens
FOU | Founder | 60 | 19-01-31 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 19-01-31 |
Ying Li Ma
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Tetlow
BRD | Director/Board Member | 64 | 22-03-28 |
Ted Love
BRD | Director/Board Member | 65 | 23-08-02 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 22-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 53.07 | -4.60% | 1,922,035 |
24-06-06 | 55.63 | -1.19% | 4,555,269 |
24-06-05 | 56.3 | +3.70% | 2,442,497 |
24-06-04 | 54.29 | +2.94% | 3,302,369 |
24-06-03 | 52.74 | +54.21% | 11,800,427 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.20% | 2.47B | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- GPCR Stock